OFIX
Orthofix Medical Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.29
−0.21%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 833.2M | 822.3M | 799.5M | 746.6M | 460.7M |
| Cost of Revenue | 253.4M | 270.6M | 253.6M | 260.4M | 123.5M |
| Gross Profit | 579.8M | 551.7M | 545.9M | 486.3M | 337.2M |
| Operating Expenses | |||||
| R&D Expense | 61.4M | 57.1M | 73.6M | 80.2M | 49.1M |
| SG&A Expense | 419.5M | 456.4M | 532.5M | 530.4M | 308.8M |
| General & Admin Expense | — | — | 532.5M | 144.7M | 80.0M |
| Selling & Marketing Expense | — | — | — | 385.7M | 228.8M |
| Other Expenses | 124.3M | 106.7M | 24.3M | 14.8M | (7.4M) |
| Total Operating Expenses | 605.2M | 620.2M | 630.5M | 625.4M | 350.4M |
| Cost and Expenses | 858.6M | 890.8M | 884.1M | 885.8M | 474.0M |
| Operating Income (EBIT) | (25.4M) | (68.5M) | (84.6M) | (139.1M) | (13.3M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 20.8M | 17.5M | 29.6M | 8.6M | 1.3M |
| Net Interest Income | (20.8M) | (17.5M) | (29.6M) | (8.6M) | (1.3M) |
| Other Non-Op Income/Expense | (34.9M) | (22.3M) | (39.3M) | (9.6M) | (4.4M) |
| Non-Operating Income (excl Interest) | 12.5M | 4.9M | 9.6M | 938.0K | 3.1M |
| EBT (Pre-Tax Income) | (60.3M) | (90.8M) | (123.9M) | (148.7M) | (17.7M) |
| Income Tax Expense | 1.4M | 1.4M | 2.1M | 2.7M | 2.0M |
| Bottom Line | |||||
| Net Income | (61.7M) | (92.2M) | (126.0M) | (151.4M) | (19.7M) |
| Earnings from Cont. Ops | (61.7M) | (92.2M) | (126.0M) | (151.4M) | (19.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (61.7M) | (92.2M) | (126.0M) | (151.4M) | (19.7M) |
| Per Share | |||||
| Basic EPS | ($1.54) | ($2.28) | ($3.30) | ($4.12) | ($0.98) |
| Diluted EPS | ($1.54) | ($2.28) | ($3.30) | ($4.12) | ($0.98) |
| Revenue Per Share | $20.37 | $20.62 | $20.97 | $20.33 | $22.92 |
| Shares | |||||
| Basic Shares Outstanding | 40.9M | 39.9M | 38.1M | 36.7M | 20.1M |
| Diluted Shares Outstanding | 40.9M | 39.9M | 38.1M | 36.7M | 20.1M |
| Profitability Metrics | |||||
| EBITDA | 107.1M | (22.4M) | (34.2M) | (79.5M) | 15.7M |
| D&A | 145.1M | 51.0M | 60.1M | 60.6M | 32.1M |
| EBIT | (37.9M) | (73.3M) | (94.2M) | (140.0M) | (16.4M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026